Research and Markets: Subarachnoid Hemorrhage - Pipeline Review, H2 2011 - A snapshot of the global therapeutic scenario for Subarachnoid Hemorrhage

DUBLIN--()--Research and Markets(http://www.researchandmarkets.com/research/d1efc1/subarachnoid_hemor) has announced the addition of Global Markets Direct's new report "Subarachnoid Hemorrhage - Pipeline Review, H2 2011" to their offering.

Global Markets Direct's, 'Subarachnoid Hemorrhage - Pipeline Review, H2 2011', provides an overview of the Subarachnoid Hemorrhage therapeutic pipeline. This report provides information on the therapeutic development for Subarachnoid Hemorrhage, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Subarachnoid Hemorrhage. 'Subarachnoid Hemorrhage - Pipeline Review, H2 2011' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

  • A review of the Subarachnoid Hemorrhage products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Subarachnoid Hemorrhage pipeline on the basis of route of administration and molecule type.
  • Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.

Key Topics Covered:

  • Introduction
  • Global Markets Direct Report Coverage
  • Subarachnoid Hemorrhage Overview
  • Therapeutics Development
  • An Overview of Pipeline Products for Subarachnoid Hemorrhage
  • Subarachnoid Hemorrhage Therapeutics under Investigation by Universities/Institutes
  • Mid Clinical Stage Products
  • Comparative Analysis
  • Subarachnoid Hemorrhage Therapeutics - Products under Investigation by Universities/Institutes
  • Subarachnoid Hemorrhage - Therapeutics Assessment
  • Assessment by Monotherapy Products
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Drug Profiles
  • Appendix
  • Methodology
  • Coverage
  • Secondary Research
  • Primary Research
  • Expert Panel Validation

For more information visit http://www.researchandmarkets.com/research/d1efc1/subarachnoid_hemor

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716